Asymchem Laboratories Tian Jin Co Ltd (002821.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100002BZ6

Price
149.26 CNY
Market cap
53.82 bn CNY
P/E (2025)
47.52
P/S (2025)
8.07
Dividend yield
0.87 %
Net margin
16.98 %
Return on equity (ROE)
6.42 %
Return on assets (ROA)
5.59 %

Asymchem Laboratories Tian Jin Co Ltd financials

Fiscal year20242025
Revenue5.80 bn CNY6.67 bn CNY
Gross profit2.41 bn CNY2.80 bn CNY
Operating income1.08 bn CNY1.25 bn CNY
EBIT618.69 m CNY1.30 bn CNY
Net income948.95 m CNY1.13 bn CNY
Diluted EPS – continuing operations2.69 CNY3.14 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Asymchem Laboratories Tian Jin Co Ltd

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 19.10.2026. Details in the risk notice.

Asymchem Laboratories Tian Jin Co Ltd stock (002821.SZ): P/E, revenue, dividend | finmetric